We show that patient-derived glioblastoma cells are capable of autocrine/paracrine TNFα-TNFR1 dependent cell death, identifying TNFR1, TNFα and NFκB as key targets in this pathway. This evidence concerns the gene TNFRSF1A and glioblastoma.